These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 10523468

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The use of insulin secretagogues in the treatment of type 2 diabetes.
    Luna B, Hughes AT, Feinglos MN.
    Prim Care; 1999 Dec; 26(4):895-915. PubMed ID: 10523467
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea].
    Ohmura E, Hosaka D, Imai Y, Kawazu S.
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():470-5. PubMed ID: 12387036
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacologic therapy for type 2 diabetes mellitus.
    DeFronzo RA.
    Ann Intern Med; 1999 Aug 17; 131(4):281-303. PubMed ID: 10454950
    [Abstract] [Full Text] [Related]

  • 9. Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes.
    Caro JJ, Klittich WS, Raggio G, Kavanagh PL, O'Brien JA, Shomphe LA, Flegel KM, Copley-Merriman C, Sigler C.
    Clin Ther; 2000 Jan 17; 22(1):116-27. PubMed ID: 10688395
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes.
    Scheen AJ, Lefèbvre PJ.
    Diabetes Care; 1999 Sep 17; 22(9):1568-77. PubMed ID: 10480527
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Targeted glycemic control in type 2 diabetes.
    Skyler JS.
    J Fla Med Assoc; 1998 Aug 17; 85(2):7-15. PubMed ID: 9782713
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid.
    Evans JL, Heymann CJ, Goldfine ID, Gavin LA.
    Endocr Pract; 2002 Aug 17; 8(1):29-35. PubMed ID: 11951812
    [Abstract] [Full Text] [Related]

  • 18. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
    Kitaoka H.
    Nihon Rinsho; 2002 Sep 17; 60 Suppl 9():464-9. PubMed ID: 12387035
    [No Abstract] [Full Text] [Related]

  • 19. Troglitazone add-on therapy to a combination of sulfonylureas plus metformin achieved and sustained effective diabetes control.
    Gavin LA, Barth J, Arnold D, Shaw R.
    Endocr Pract; 2000 Sep 17; 6(4):305-10. PubMed ID: 11242607
    [Abstract] [Full Text] [Related]

  • 20. [Troglitazone].
    Yamanouchi T.
    Nihon Rinsho; 2000 Feb 17; 58(2):389-94. PubMed ID: 10707563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.